United Kingdom· GB-APID-17463611000001107
Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset
A aztreonam product containing aztreonam, registered in United Kingdom by Gilead Sciences Ltd. The same ATC class is registered in 16 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Aztreonam is registered in 16 of 19 countries.
Countries holding a registration under ATC J01DF01 (aztreonam), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Aztreonam · ATC J01DF01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of aztreonam costs, country by country.
Normalised to the WHO defined daily dose (0.225 g), the median price runs from $4.80 in Spain to $107.66 in Switzerland — a ×22 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Aztreonam · price per daily dose (0.225 g)
USD · FX 28 Sept 2026
- CH Switzerland$107.66
- ES Spain$4.80
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Aztreonam
- Manufacturer
- Gilead Sciences Ltd
- Country
- United Kingdom (GB)
- ATC code
- J01DF01
- ATC class
- Aztreonam
- Defined daily dose
- 0.225 g, Inhal
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5391507140289
- gtin05391507145284
- gtin05391507145291
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
40 interactions on record for aztreonam.
Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aztreonam · interactions on record
40 records
- 10 moderate
- 30 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Levonorgestrel and ethinylestradiolG03AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Aztreonam in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCAYSTON 75 mg POLVO Y DISOLVENTE PARA SOLUCION PARA INHALACION POR NEBULIZADORGilead Sciences Ireland Unlimited Company
- IrelandCayston 75 mg powder and solvent for nebuliser solution.Gilead Sciences Ireland UC
- PolandCaystonGilead Sciences Ireland UC
- United StatesAZACTAMA-S Medication Solutions
- BelgiumAzactam 1 gLaboratoires Delbert
- FinlandAzactamLaboratoires Delbert x
- FranceAZACTAM 1 g, poudre pour solution injectable/pour perfusionLABORATOIRES DELBERT
- SwitzerlandAzactam 2 g, poudre pour solution injectable/pour perfusionLeman SKL SA
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Azactam
- Belgium · Azactam
- Spain · Azactam
- Finland · Azactam
- France · Azactam
- Ireland · Azactam
- Iceland · Cayston
- Liechtenstein · Cayston
- Luxembourg · Azactam
- Norway · Azactam, Cayston
- Portugal · Azactam
- Romania · Azactam
- Sweden · Azactam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cadb8258-148f-49b8-bc75-d653b37fab73 GET /v1/drugs/cadb8258-148f-49b8-bc75-d653b37fab73?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "17463611000001107",
"desc": "Cayston 75mg powder and solvent for nebuliser solution vials with Altera Nebuliser Handset (Gilead Sciences Ltd)",
"form": "Powder and solvent for nebuliser solution",
"vpid": "17463411000001109",
"source": "dmd",
"vtm_id": "774725007",
"strength": "75 mg",
"substance": "Aztreonam",
"ingredient": "Aztreonam lysine",
"supplier_code": "2572301000001107"
}See everything about aztreonam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.